Cargando…

Benzodiazepine Sedation and Postoperative Neurological Deficits after Awake Craniotomy for Brain Tumor – An Exploratory Retrospective Cohort Study

An awake craniotomy is a common neurosurgical procedure for excising brain tumor(s) located near or in eloquent areas. The use of benzodiazepine (BZD) for sedation in some patients with neuropathological conditions (e.g., stroke, brain tumors) has been previously linked with re-appearance of neurolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Plitman, Eric, Chowdhury, Tumul, Paquin-Lanthier, Gabriel, Takami, Hirokazu, Subramaniam, Sudhakar, Leong, Kok Weng, Daniels, Abigail, Bernstein, Mark, Venkatraghavan, Lashmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065444/
https://www.ncbi.nlm.nih.gov/pubmed/35515117
http://dx.doi.org/10.3389/fonc.2022.885164
_version_ 1784699589503221760
author Plitman, Eric
Chowdhury, Tumul
Paquin-Lanthier, Gabriel
Takami, Hirokazu
Subramaniam, Sudhakar
Leong, Kok Weng
Daniels, Abigail
Bernstein, Mark
Venkatraghavan, Lashmi
author_facet Plitman, Eric
Chowdhury, Tumul
Paquin-Lanthier, Gabriel
Takami, Hirokazu
Subramaniam, Sudhakar
Leong, Kok Weng
Daniels, Abigail
Bernstein, Mark
Venkatraghavan, Lashmi
author_sort Plitman, Eric
collection PubMed
description An awake craniotomy is a common neurosurgical procedure for excising brain tumor(s) located near or in eloquent areas. The use of benzodiazepine (BZD) for sedation in some patients with neuropathological conditions (e.g., stroke, brain tumors) has been previously linked with re-appearance of neurological deficits including limb incoordination, ataxia, and motor weakness, resulting in complications for the patient along with procedural challenges. Whether or not these findings can be extrapolated to patients undergoing brain tumor resection is largely unknown. The current work primarily sought to compare neurological outcome(s) in the immediate postoperative period between BZD-free and BZD-based sedation techniques in patients undergoing awake craniotomy. Using a database composed of awake craniotomies conducted within a single center and by a single surgeon, patients were retrospectively classified based on midazolam administration into BZD-free sedation (n=125) and BZD-based sedation (n=416) groups. Patients from each group were matched based on age, sex, tumor location, tumor grade, preoperative neurological deficits, non-operative BZD use, and Karnofsky Performance Scale scores, resulting in 108 patients within each group. Postoperative neurological deficits were recorded. Logistic regression analyses were conducted comparing postoperative neurological deficits between the matched groups. Postoperative neurological deficits were more prevalent within the BZD-based sedation group compared to the BZD-free sedation group (adjusted odds ratio (aOR)=1.903, 95% CI=1.018-3.560, p=0.044). In addition, subgroup analysis of the matched cohort showed a relationship between preoperative neurological symptoms and postoperative neurological deficits in the BZD-based sedation group (aOR=3.756, 95% CI=1.390-10.147, p=0.009). Our findings support the notion that the increased incidence of postoperative neurological deficits with BZD sedation may in part be related to the unmasking of preoperative neurological deficits. Further studies are required to confirm this phenomenon.
format Online
Article
Text
id pubmed-9065444
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90654442022-05-04 Benzodiazepine Sedation and Postoperative Neurological Deficits after Awake Craniotomy for Brain Tumor – An Exploratory Retrospective Cohort Study Plitman, Eric Chowdhury, Tumul Paquin-Lanthier, Gabriel Takami, Hirokazu Subramaniam, Sudhakar Leong, Kok Weng Daniels, Abigail Bernstein, Mark Venkatraghavan, Lashmi Front Oncol Oncology An awake craniotomy is a common neurosurgical procedure for excising brain tumor(s) located near or in eloquent areas. The use of benzodiazepine (BZD) for sedation in some patients with neuropathological conditions (e.g., stroke, brain tumors) has been previously linked with re-appearance of neurological deficits including limb incoordination, ataxia, and motor weakness, resulting in complications for the patient along with procedural challenges. Whether or not these findings can be extrapolated to patients undergoing brain tumor resection is largely unknown. The current work primarily sought to compare neurological outcome(s) in the immediate postoperative period between BZD-free and BZD-based sedation techniques in patients undergoing awake craniotomy. Using a database composed of awake craniotomies conducted within a single center and by a single surgeon, patients were retrospectively classified based on midazolam administration into BZD-free sedation (n=125) and BZD-based sedation (n=416) groups. Patients from each group were matched based on age, sex, tumor location, tumor grade, preoperative neurological deficits, non-operative BZD use, and Karnofsky Performance Scale scores, resulting in 108 patients within each group. Postoperative neurological deficits were recorded. Logistic regression analyses were conducted comparing postoperative neurological deficits between the matched groups. Postoperative neurological deficits were more prevalent within the BZD-based sedation group compared to the BZD-free sedation group (adjusted odds ratio (aOR)=1.903, 95% CI=1.018-3.560, p=0.044). In addition, subgroup analysis of the matched cohort showed a relationship between preoperative neurological symptoms and postoperative neurological deficits in the BZD-based sedation group (aOR=3.756, 95% CI=1.390-10.147, p=0.009). Our findings support the notion that the increased incidence of postoperative neurological deficits with BZD sedation may in part be related to the unmasking of preoperative neurological deficits. Further studies are required to confirm this phenomenon. Frontiers Media S.A. 2022-04-20 /pmc/articles/PMC9065444/ /pubmed/35515117 http://dx.doi.org/10.3389/fonc.2022.885164 Text en Copyright © 2022 Plitman, Chowdhury, Paquin-Lanthier, Takami, Subramaniam, Leong, Daniels, Bernstein and Venkatraghavan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Plitman, Eric
Chowdhury, Tumul
Paquin-Lanthier, Gabriel
Takami, Hirokazu
Subramaniam, Sudhakar
Leong, Kok Weng
Daniels, Abigail
Bernstein, Mark
Venkatraghavan, Lashmi
Benzodiazepine Sedation and Postoperative Neurological Deficits after Awake Craniotomy for Brain Tumor – An Exploratory Retrospective Cohort Study
title Benzodiazepine Sedation and Postoperative Neurological Deficits after Awake Craniotomy for Brain Tumor – An Exploratory Retrospective Cohort Study
title_full Benzodiazepine Sedation and Postoperative Neurological Deficits after Awake Craniotomy for Brain Tumor – An Exploratory Retrospective Cohort Study
title_fullStr Benzodiazepine Sedation and Postoperative Neurological Deficits after Awake Craniotomy for Brain Tumor – An Exploratory Retrospective Cohort Study
title_full_unstemmed Benzodiazepine Sedation and Postoperative Neurological Deficits after Awake Craniotomy for Brain Tumor – An Exploratory Retrospective Cohort Study
title_short Benzodiazepine Sedation and Postoperative Neurological Deficits after Awake Craniotomy for Brain Tumor – An Exploratory Retrospective Cohort Study
title_sort benzodiazepine sedation and postoperative neurological deficits after awake craniotomy for brain tumor – an exploratory retrospective cohort study
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065444/
https://www.ncbi.nlm.nih.gov/pubmed/35515117
http://dx.doi.org/10.3389/fonc.2022.885164
work_keys_str_mv AT plitmaneric benzodiazepinesedationandpostoperativeneurologicaldeficitsafterawakecraniotomyforbraintumoranexploratoryretrospectivecohortstudy
AT chowdhurytumul benzodiazepinesedationandpostoperativeneurologicaldeficitsafterawakecraniotomyforbraintumoranexploratoryretrospectivecohortstudy
AT paquinlanthiergabriel benzodiazepinesedationandpostoperativeneurologicaldeficitsafterawakecraniotomyforbraintumoranexploratoryretrospectivecohortstudy
AT takamihirokazu benzodiazepinesedationandpostoperativeneurologicaldeficitsafterawakecraniotomyforbraintumoranexploratoryretrospectivecohortstudy
AT subramaniamsudhakar benzodiazepinesedationandpostoperativeneurologicaldeficitsafterawakecraniotomyforbraintumoranexploratoryretrospectivecohortstudy
AT leongkokweng benzodiazepinesedationandpostoperativeneurologicaldeficitsafterawakecraniotomyforbraintumoranexploratoryretrospectivecohortstudy
AT danielsabigail benzodiazepinesedationandpostoperativeneurologicaldeficitsafterawakecraniotomyforbraintumoranexploratoryretrospectivecohortstudy
AT bernsteinmark benzodiazepinesedationandpostoperativeneurologicaldeficitsafterawakecraniotomyforbraintumoranexploratoryretrospectivecohortstudy
AT venkatraghavanlashmi benzodiazepinesedationandpostoperativeneurologicaldeficitsafterawakecraniotomyforbraintumoranexploratoryretrospectivecohortstudy